Wound Management Technologies Inc  

(Public, OTCMKTS:WNDM)   Watch this stock  
Find more results for PINK:WNDM
0.0000 (0.00%)
Nov 25 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.02 - 0.11
Open     -
Vol / Avg. 0.00/38,462.00
Mkt cap 7.25M
P/E     -
Div/yield     -
EPS -0.02
Shares 107.34M
Beta 0.26
Inst. own 0%
Oct 7, 2015
Q3 2015 Wound Management Technologies Inc Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -78.15% -86.54%
Operating margin -72.67% -78.34%
EBITD margin - -76.20%
Return on average assets -169.86% -184.06%
Return on average equity - -
Employees 4 -
CDP Score - -


Suite 3100 777 Main Street
United States - Map
+1-817-8207080 (Phone)

Website links


Wound Management Technologies, Inc. distributes collagen-based wound care products to healthcare providers, such as physicians, clinics and hospitals. The Company has three wholly owned subsidiaries: Wound Care Innovations, LLC, Resorbable Orthopedic Products, LLC and BioPharma Management Technologies, Inc. The Company's CellerateRX is a medical device for use on all acute and chronic wounds, except third degree burns and is ready for distribution in both gel and powder form. Manufacturing of these products is conducted by Applied Nutritionals, LLC (Applied Nutritionals), which owns the CellerateRX trademark.

Officers and directors

Deborah Jenkins Hutchinson President
Age: 56
Darren Stine Chief Financial Officer
Age: 44
Cathy Bradshaw President of Wound Care Innovations, LLC
Age: 61
S. Oden Howell Jr. Director
Age: 75
James W. Stuckert Director
Age: 77
Philip J. Rubinfeld Independent Director
Age: 59
John Siedhoff Independent Director
Age: 55